Ionis Pharma (IONS) Tops Q2 EPS by 5c
Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.
Ionis Pharma (NASDAQ: IONS) reported Q2 EPS of ($0.47), $0.05 better than the analyst estimate of ($0.52). Revenue for the quarter came in at $38.5 million versus the consensus estimate of $38.52 million.
For earnings history and earnings-related data on Ionis Pharma (IONS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- NeoGenomics (NEO) Tops Q3 EPS by 1c; Boosts FY16 EPS Outlook
- Logitech (LOGI) Tops Q2 EPS by 10c
- Arlington Asset Investment (AI) Misses Q3 EPS by 2c
Create E-mail Alert Related CategoriesEarnings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!